HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT ON DECEMBER 31, 2025
06 Jan 2026 17:45 CET
Issuer
DIAGNOSTIC MEDICAL SYSTEMS
January 6, 2026 – 5.45 pm – Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 – ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, communicates the half-year results of the liquidity contract entrusted by DIAGNOSTIC MEDICAL SYSTEMS to NATIXIS ODDO BHF dated May 7, 2025.
As of 31/12/2025, the following resources were included in the dedicated liquidity account:
- 110 630 Shares
- 102 349 Euros
It should be noted that when the contract was set up, the following resources were included in the dedicated liquidity account:
- 150 000 Shares
- 50 000 Euros
Over the period from 01/07/2025 to 31/12/2025 were executed:
- 1 155 Purchase transactions
- 1 153 Sale Transactions
Over the same period, the volumes traded represented:
- 248 152 Shares and 330 540 euros on purchase
- 253 627 Shares and 342 117 euros for sale
UPCOMING EVENTS* :
- 19/01/2026 2025 Annual revenue 2025
- 14/04/2026 2025 Annual results
- 21/04/2026 Q1 2026 revenue
The publications will take place after the close of the Euronext Paris market.
*Provisional schedule subject to change. Visit the DMS Group website.
Find financial information on our investor area: www.dms.com
Receive free financial information from DMS Group by registering on www.actusnews.com
ABOUT DMS GROUP
DMS Group is a French digital radiology manufacturer, internationally oriented, recognized as a key player and a key partner in the value chain, both for the quality of its solutions, and for its flexibility, ingenuity and responsible values.
In 2024, DMS Group achieved a consolidated turnover of €46.1 million, more than 75% of which was international, with a presence on all continents through a network of more than 140 national distributors.
DMS Group is listed on the Euronext Growth Paris market (ISIN: FR0012202497 - ticker: ALDMS) and is eligible for the PEA PME-ETI.
DMS Group is part of the ETIncelles program for SMEs that have the ambition and the desire to become mid-caps.
| CONTACTS DMS GROUP Investor Relations relationinvestisseur@dms-imaging.com Press Relations relationpresse@dms-imaging.com |
CONTACTS NEWS Mathieu OMNES Analyst and Investor RelationsTel.: 01 53 67 36 92 momnes@actus.fr Fatou-Kiné N'DIAYE Press Relations Tel.: 01 53 67 36 34 fndiaye@actus.fr |
- SECURITY MASTER Key: lGtqkpdqZWjImZ6elMqbm2eUmW5jx2SVZWWWmGdtaZ2Yap1iyG1mbcieZnJmnG5p
- Check this key: https://www.security-master-key.com.
Regulated information:
Acquisition or disposal of the issuer's own shares:
- Information relating to the liquidity contract
Full and original press release in PDF: https://www.actusnews.com/news/95793-dms-group-cp-2025.12.31-half-year-report-on-the-liquidity-en.pdf
Source
DMS GROUP
Provider
ActusNewsWire
Company Name
DIAGNOSTIC MEDICAL SYSTEMS
ISIN
FR0012202497
Symbol
ALDMS
Market
Euronext Growth